{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T15:10:35Z","timestamp":1793373035014,"version":"4.5.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2010,12,16]],"date-time":"2010-12-16T00:00:00Z","timestamp":1292457600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Neuropathol"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1007\/s00401-010-0788-5","type":"journal-article","created":{"date-parts":[[2010,12,15]],"date-time":"2010-12-15T15:15:19Z","timestamp":1292426119000},"page":"487-498","source":"Crossref","is-referenced-by-count":160,"title":["Modulation of lipid peroxidation and mitochondrial function improves neuropathology in Huntington\u2019s disease mice"],"prefix":"10.1007","volume":"121","author":[{"given":"Junghee","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bela","family":"Kosaras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve J.","family":"Del Signore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerry","family":"Cormier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"McKee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajiv R.","family":"Ratan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil W.","family":"Kowall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoon","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,12,16]]},"reference":[{"key":"788_CR1","first-page":"131","volume":"59","author":"DS Albers","year":"2000","unstructured":"Albers DS, Beal MF (2000) Mitochondrial dysfunction and oxidative stress in aging and neurodegenerative disease. J Neural Transm Suppl 59:131\u2013154","journal-title":"J Neural Transm Suppl"},{"key":"788_CR2","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jep.2005.02.002","volume":"98","author":"S Arteaga","year":"2005","unstructured":"Arteaga S, Andrade-Cetto A, C\u00e1rdenas R (2005) Larrea tridentata (Creosote bush), an abundant plant of Mexican and US-American deserts and its metabolite nordihydroguaiaretic acid. J Ethnopharmacol 98:231\u2013239","journal-title":"J Ethnopharmacol"},{"key":"788_CR3","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/ana.410380304","volume":"38","author":"MF Beal","year":"1995","unstructured":"Beal MF (1995) Aging, energy and oxidative stress in neurodegenerative diseases. Ann Neurol 38:357\u2013366","journal-title":"Ann Neurol"},{"key":"788_CR4","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nrn1386","volume":"5","author":"MF Beal","year":"2004","unstructured":"Beal MF, Ferrante RJ (2004) Experimental therapeutics in transgenic mouse models of Huntington\u2019s disease. Nat Rev Neurosci 5:373\u2013384","journal-title":"Nat Rev Neurosci"},{"key":"788_CR5","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/nchembio782","volume":"2","author":"DA Bosco","year":"2006","unstructured":"Bosco DA, Fowler DM, Zhang Q, Nieva J, Powers ET, Wentworth P Jr et al (2006) Elevated levels of oxidized cholesterol metabolites in Lewy body disease brains accelerate alpha-synuclein fibrilization. Nat Chem Biol 2:249\u2013253","journal-title":"Nat Chem Biol"},{"key":"788_CR6","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1089\/ars.2006.8.2061","volume":"8","author":"SE Browne","year":"2006","unstructured":"Browne SE, Beal MF (2006) Oxidative damage in Huntington\u2019s disease pathogenesis. Antioxid Redox Signal 8:2061\u20132073","journal-title":"Antioxid Redox Signal"},{"key":"788_CR7","doi-asserted-by":"crossref","first-page":"623","DOI":"10.3109\/10715769809065818","volume":"28","author":"M Comporti","year":"1998","unstructured":"Comporti M (1998) Lipid peroxidation and biogenic aldehydes: from the identification of 4-hydroxynonenal to further achievements in biopathology. Free Radic Res 28:623\u2013635","journal-title":"Free Radic Res"},{"key":"788_CR8","doi-asserted-by":"crossref","first-page":"9418","DOI":"10.1523\/JNEUROSCI.23-28-09418.2003","volume":"23","author":"RJ Ferrante","year":"2003","unstructured":"Ferrante RJ, Kubilus JK, Lee J, Ryu H, Beesen A, Zucker B et al (2003) Histone deacetylase inhibition by sodium butyrate chemotherapy ameliorates the neurodegenerative phenotype in Huntington\u2019s disease mice. J Neurosci 23:9418\u20139427","journal-title":"J Neurosci"},{"key":"788_CR9","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0361-9230(01)00577-9","volume":"56","author":"KH Fischbeck","year":"2001","unstructured":"Fischbeck KH (2001) Polyglutamine expansion neurodegenerative disease. Brain Res Bull 56:161\u2013163","journal-title":"Brain Res Bull"},{"key":"788_CR10","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/j.lfs.2003.08.012","volume":"74","author":"N Fujimoto","year":"2004","unstructured":"Fujimoto N, Kohta R, Kitamura S, Honda H (2004) Estrogenic activity of an antioxidant, nor dihydroguaiaretic acid (NDGA). Life Sci 74:1417\u20131425","journal-title":"Life Sci"},{"key":"788_CR11","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0006-8993(94)91586-5","volume":"654","author":"Y Goodman","year":"1994","unstructured":"Goodman Y, Steiner MR, Steiner SM, Mattson MP (1994) Nordihydroguaiaretic acid protects hippocampal neurons against amyloid beta-peptide toxicity, and attenuates free radical and calcium accumulation. Brain Res 654:171\u2013176","journal-title":"Brain Res"},{"key":"788_CR12","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/(SICI)1097-4547(19980701)53:1<66::AID-JNR7>3.0.CO;2-H","volume":"53","author":"ED Hall","year":"1998","unstructured":"Hall ED, Andrus PK, Oostveen JA, Fleck TJ, Gurney ME (1998) Relationship of oxygen radical-induced lipid peroxidative damage to disease onset and progression in a transgenic model of familial ALS. J Neurosci Res 53:66\u201377","journal-title":"J Neurosci Res"},{"key":"788_CR13","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.2353\/ajpath.2009.090417","volume":"175","author":"T Hamaguchi","year":"2009","unstructured":"Hamaguchi T, Ono K, Murase A, Yamada M (2009) Phenolic compounds prevent Alzheimer\u2019s pathology through different effects on the amyloid-beta aggregation pathway. Am J Pathol 175:2557\u20132565","journal-title":"Am J Pathol"},{"key":"788_CR14","unstructured":"Hersch SM, Ferrante RJ (1997) Neuropathology and pathophysiology of Huntington\u2019s disease. In: Watts RL, Koller WC (eds) Movement disorders: neurologic principles and practice. McGraw-Hill, New York, pp 503\u2013518"},{"key":"788_CR15","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","volume":"72","author":"Huntington\u2019s Disease Collaborative Research Group","year":"1993","unstructured":"Huntington\u2019s Disease Collaborative Research Group (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes. Cell 72:971\u2013983","journal-title":"Cell"},{"key":"788_CR16","doi-asserted-by":"crossref","first-page":"e135","DOI":"10.1371\/journal.pgen.0030135","volume":"3","author":"JM Lee","year":"2007","unstructured":"Lee JM, Ivanova EV, Seong IS, Cashorali T, Kohane I, Gusella JF, MacDonald ME (2007) Unbiased gene expression analysis implicates the huntingtin polyglutamine tract in extra-mitochondrial energy metabolism. PLoS Genet 3:e135","journal-title":"PLoS Genet"},{"key":"788_CR17","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/(SICI)1097-4547(19991115)58:4<515::AID-JNR5>3.0.CO;2-F","volume":"58","author":"MS Levine","year":"1999","unstructured":"Levine MS, Klapstein GJ, Koppel A, Gruen E, Cepeda C, Vargas ME et al (1999) Enhanced sensitivity to N-methyl-d-aspartate receptor activation in transgenic and knockin mouse models of Huntington\u2019s disease. J Neurosci Res 58:515\u2013532","journal-title":"J Neurosci Res"},{"key":"788_CR18","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0896-6273(00)80953-8","volume":"19","author":"Y Li","year":"1997","unstructured":"Li Y, Maher P, Schubert D (1997) A role for 12-lipoxygenase in nerve cell death caused by glutathione depletion. Neuron 19:453\u2013463","journal-title":"Neuron"},{"key":"788_CR19","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.nbd.2009.08.003","volume":"36","author":"X Li","year":"2009","unstructured":"Li X, Sapp E, Chase K, Comer-Tierney LA, Masso N, Alexander J, Reeves P, Kegel KB, Valencia A, Esteves M, Aronin N, Difiglia M (2009) Disruption of Rab11 activity in a knock-in mouse model of Huntington\u2019s disease. Neurobiol Dis 36:374\u2013383","journal-title":"Neurobiol Dis"},{"key":"788_CR20","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","volume":"87","author":"L Mangiarini","year":"1996","unstructured":"Mangiarini L, Sathasivam K, Seller M, Cozens B, Harper A, Hetherington C, Lawton M, Trottier Y, Lehrach H, Davies SW, Bates GP (1996) Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87:493\u2013506","journal-title":"Cell"},{"key":"788_CR21","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1093\/qjmed\/94.9.485","volume":"94","author":"LT McGrath","year":"2001","unstructured":"McGrath LT, McGleenon BM, Brennan S, McColl D, McILroy S, Passmore AP (2001) Increased oxidative stress in Alzheimer\u2019s disease as assessed with 4-hydroxynonenal but not malondialdehyde. QJM 94:485\u2013490","journal-title":"QJM"},{"key":"788_CR22","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S0891-5849(02)00807-9","volume":"33","author":"TJ Montine","year":"2002","unstructured":"Montine TJ, Neely MD, Quinn JF, Beal MF, Markesbery WR, Roberts LJ et al (2002) Lipid peroxidation in aging brain and Alzheimer\u2019s disease. Free Radic Biol Med 33:620\u2013626","journal-title":"Free Radic Biol Med"},{"key":"788_CR23","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1046\/j.1471-4159.1999.0722323.x","volume":"72","author":"MD Neely","year":"1999","unstructured":"Neely MD, Sidell KR, Graham DG, Montine TJ (1999) The lipid peroxidation product 4-hydroxynonenal inhibits neurite outgrowth, disrupts neuronal microtubules, and modifies cellular tubulin. J Neurochem 72:2323\u20132333","journal-title":"J Neurochem"},{"key":"788_CR24","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.brainres.2004.12.027","volume":"1037","author":"MD Neely","year":"2005","unstructured":"Neely MD, Boutte A, Milatovic D, Montine TJ (2005) Mechanisms of 4-hydroxynonenal-induced neuronal microtubule dysfunction. Brain Res 1037:90\u201398","journal-title":"Brain Res"},{"key":"788_CR25","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S0166-2236(99)01534-9","volume":"23","author":"DG Nicholls","year":"2000","unstructured":"Nicholls DG, Ward MW (2000) Mitochondrial membrane potential and neuronal glutamate excitotoxicity: mortality and millivolts. Trends Neurosci 23:166\u2013174","journal-title":"Trends Neurosci"},{"key":"788_CR26","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1046\/j.1471-4159.2002.00904.x","volume":"81","author":"K Ono","year":"2002","unstructured":"Ono K, Hasegawa K, Yoshiike Y, Takashima A, Yamada M, Naiki H (2002) Nordihydroguaiaretic acid potently breaks down pre-formed Alzheimer\u2019s beta-amyloid fibrils in vitro. J Neurochem 81:434\u2013440","journal-title":"J Neurochem"},{"key":"788_CR27","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1471-4159.2006.03707.x","volume":"97","author":"K Ono","year":"2006","unstructured":"Ono K, Yamada M (2006) Antioxidant compounds have potent anti-fibrillogenic and fibril-destabilizing effects for alpha-synuclein fibrils in vitro. J Neurochem 97:105\u2013115","journal-title":"J Neurochem"},{"key":"788_CR28","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1523\/JNEUROSCI.0106-08.2008","volume":"28","author":"AL Orr","year":"2008","unstructured":"Orr AL, Li S, Wang CE, Li H, Wang J, Rong J, Xu X, Mastroberardino PG, Greenamyre JT, Li XJ (2008) N-terminal mutant huntingtin associates with mitochondria and impairs mitochondrial trafficking. J Neurosci 28:2783\u20132792","journal-title":"J Neurosci"},{"key":"788_CR29","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1440-1789.2006.00662.x","volume":"26","author":"R Oyamada","year":"2006","unstructured":"Oyamada R, Hayashi M, Katoh Y, Tsuchiya K, Mizutani T, Tominaga I et al (2006) Neurofibrillary tangles and deposition of oxidative products in the brain in cases of myotonic dystrophy. Neuropathology 26:107\u2013114","journal-title":"Neuropathology"},{"key":"788_CR30","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nn884","volume":"5","author":"AV Panov","year":"2002","unstructured":"Panov AV, Gutekunst CA, Leavitt BR, Hayden MR, Burke JR, Strittmatter WJ et al (2002) Early mitochondrial calcium defects in Huntington\u2019s disease are a direct effect of polyglutamines. Nat Neurosci 5:731\u2013736","journal-title":"Nat Neurosci"},{"key":"788_CR31","doi-asserted-by":"crossref","first-page":"36987","DOI":"10.1074\/jbc.M702146200","volume":"282","author":"IM Qahwash","year":"2007","unstructured":"Qahwash IM, Boire A, Lanning J, Krausz T, Pytel P, Meredith SC (2007) Site-specific effects of peptide lipidation on beta-amyloid aggregation and cytotoxicity. J Biol Chem 282:36987\u201336997","journal-title":"J Biol Chem"},{"key":"788_CR32","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0076-6879(02)52018-8","volume":"352","author":"RR Ratan","year":"2002","unstructured":"Ratan RR, Ryu H, Lee J, Mwidau A, Neve RL (2002) In vitro model of oxidative stress in cortical neurons. Methods Enzymol 352:183\u2013190","journal-title":"Methods Enzymol"},{"key":"788_CR33","doi-asserted-by":"crossref","first-page":"4281","DOI":"10.1073\/pnas.0737363100","volume":"100","author":"H Ryu","year":"2003","unstructured":"Ryu H, Lee J, Olofsson BA, Mwidau A, Dedeoglu A, Escudero M et al (2003) Histone deacetylase inhibitors prevent oxidative neuronal death independent of expanded polyglutamine repeats via an SP1-dependent pathway. Proc Natl Acad Sci USA 100:4281\u20134286","journal-title":"Proc Natl Acad Sci USA"},{"key":"788_CR34","doi-asserted-by":"crossref","first-page":"3597","DOI":"10.1523\/JNEUROSCI.23-09-03597.2003","volume":"23","author":"H Ryu","year":"2003","unstructured":"Ryu H, Lee J, Zaman K, Kubilis J, Ferrante RJ, Ross BD et al (2003) SP1 and SP3 are oxidative stress-inducible, anti-death transcription factors in cortical neurons. J Neurosci 23:3597\u20133606","journal-title":"J Neurosci"},{"key":"788_CR35","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1517\/14728214.10.2.345","volume":"10","author":"H Ryu","year":"2005","unstructured":"Ryu H, Ferrante RJ (2005) Emerging chemotherapeutic strategies for Huntington\u2019s disease. Expert Opin Emerg Drugs 10:345\u2013363","journal-title":"Expert Opin Emerg Drugs"},{"key":"788_CR36","doi-asserted-by":"crossref","first-page":"19176","DOI":"10.1073\/pnas.0606373103","volume":"103","author":"H Ryu","year":"2006","unstructured":"Ryu H, Lee J, Hagerty SW, Soh BY, McAlpin SE, Cormier KA et al (2006) ESET\/SETDB1 gene expression and histone H3 (K9) trimethylation in Huntington\u2019s disease. Proc Natl Acad Sci USA 103:19176\u201319181","journal-title":"Proc Natl Acad Sci USA"},{"key":"788_CR37","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1038\/13518","volume":"5","author":"A Sawa","year":"1999","unstructured":"Sawa A, Wiegand GW, Cooper J, Margolis RL, Sharp AH, Lawler JF Jr et al (1999) Increased apoptosis of Huntington disease lymphoblasts associated with repeat length-dependent mitochondrial depolarization. Nat Med 5:1194\u20131198","journal-title":"Nat Med"},{"key":"788_CR38","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0098-2997(03)00009-8","volume":"24","author":"RJ Schaur","year":"2003","unstructured":"Schaur RJ (2003) Basic aspects of the biochemical reactivity of 4-hydroxynonenal. Mol Aspects Med 24:149\u2013159","journal-title":"Mol Aspects Med"},{"key":"788_CR39","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/hmg\/8.3.397","volume":"8","author":"G Schilling","year":"1999","unstructured":"Schilling G, Becher MW, Sharp AH, Jinnah HA, Duan K, Kotzuk JA et al (1999) Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin. Hum Mol Genet 8:397\u2013407","journal-title":"Hum Mol Genet"},{"key":"788_CR40","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1096\/fj.06-7828com","volume":"21","author":"A Sexton","year":"2007","unstructured":"Sexton A, McDonald M, Cayla C, Thiemermann C, Ahluwalia A (2007) 12-Lipoxygenase-derived eicosanoids protect against myocardial ischemia\/reperfusion injury via activation of neuronal TRPV1. FASEB J 21:2695\u20132703","journal-title":"FASEB J"},{"key":"788_CR41","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0091-3057(01)00572-X","volume":"69","author":"Y Shishido","year":"2001","unstructured":"Shishido Y, Furushiro M, Hashimoto S, Yokokura T (2001) Effect of nordihydroguaiaretic acid on behavioral impairment and neuronal cell death after forebrain ischemia. Pharmacol Biochem Behav 69:469\u2013474","journal-title":"Pharmacol Biochem Behav"},{"key":"788_CR42","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1021\/bi061853s","volume":"46","author":"SJ Siegel","year":"2007","unstructured":"Siegel SJ, Bieschke J, Powers ET, Kelly JW (2007) The oxidative stress metabolite 4 hydroxynonenal promotes Alzheimer protofibril formation. Biochemistry 46:1503\u20131510","journal-title":"Biochemistry"},{"key":"788_CR43","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1042\/BJ20051277","volume":"393","author":"A Trostchansky","year":"2006","unstructured":"Trostchansky A, Lind S, Hodara R, Oe T, Blair IA, Ischiropoulos H et al (2006) Interaction with phospholipids modulates alpha-synuclein nitration and lipid-protein adduct formation. Biochem J 393:343\u2013349","journal-title":"Biochem J"},{"key":"788_CR44","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.pneurobio.2006.11.004","volume":"83","author":"R Truant","year":"2007","unstructured":"Truant R, Atwal RS, Burtnik A (2007) Nucleocytoplasmic trafficking and transcription effects of huntingtin in Huntington\u2019s disease. Prog Neurobiol 83:211\u2013227","journal-title":"Prog Neurobiol"},{"key":"788_CR45","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.neuroscience.2006.10.056","volume":"145","author":"E Trushina","year":"2007","unstructured":"Trushina E, McMurray CT (2007) Oxidative stress and mitochondrial dysfunction in neurodegenerative diseases. Neuroscience 145:1233\u20131248","journal-title":"Neuroscience"},{"key":"788_CR46","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","volume":"44","author":"JP Vonsattel","year":"1985","unstructured":"Vonsattel JP, Myers RH, Stevens TJ, Ferrante RJ, Bird ED, Richardson EP Jr (1985) Neuropathological classification of Huntington\u2019s disease. J Neuropathol Exp Neurol 44:559\u2013577","journal-title":"J Neuropathol Exp Neurol"},{"key":"788_CR47","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00401-007-0306-6","volume":"115","author":"JP Vonsattel","year":"2008","unstructured":"Vonsattel JP (2008) Huntington disease models and human neuropathology: similarities and differences. Acta Neuropathol 115:55\u201369","journal-title":"Acta Neuropathol"},{"key":"788_CR48","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0098-2997(03)00024-4","volume":"24","author":"K Zarkovic","year":"2003","unstructured":"Zarkovic K (2003) 4-Hydroxynonenal and neurodegenerative diseases. Mol Aspects Med 24:293\u2013303","journal-title":"Mol Aspects Med"}],"container-title":["Acta Neuropathologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-010-0788-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00401-010-0788-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-010-0788-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,7]],"date-time":"2019-06-07T03:10:14Z","timestamp":1559877014000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00401-010-0788-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12,16]]},"references-count":48,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["788"],"URL":"https:\/\/doi.org\/10.1007\/s00401-010-0788-5","relation":{},"ISSN":["0001-6322","1432-0533"],"issn-type":[{"value":"0001-6322","type":"print"},{"value":"1432-0533","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,12,16]]}}}